Release date for Belgium will be mid September, that's correct.Think it'll be September in all European markets? Isn't September the confirmed Belgian date?
Release date for Belgium will be mid September, that's correct.Think it'll be September in all European markets? Isn't September the confirmed Belgian date?
Not a great deal if I'm honest. There's Otonomy's OTO-313 that is in its early stages (will be years away at best) and that's even if it helps chronic cases.Is there anything else in the pipeline for the ones it does not help?
Where is this confirmed?Release date for Belgium will be mid September, that's correct.
I got an email back from Sven Vanneste, a Belgian professor who is a scientific advisor for Neuromod and he said that's the expected release date for Belgium.Where is this confirmed?
Is there anything else in the pipeline for the ones it does not help?
The device may be further refined or similar devices such as University of Michigan or University of Minnesota may become available as well, if that counts.Not a great deal if I'm honest. There's Otonomy's OTO-313 that is in its early stages (will be years away at best) and that's even if it helps chronic cases.
The potassium channel drug XEN-1101 that's not even targeted for tinnitus but for epilepsy MIGHT help tinnitus in its early stages.
Any other KV3 channel drugs are still in preclinical trials.
And of course hair cell regeneration or synapse repair will be years away.
This literally is all we have unless a serendipitous discovery comes along.
Good point @Manny. I forgot about those devices, I guess I was just tarring them off on the same brush as they all fall under bimodal neuromodulation.The device may be further refined or similar devices such as University of Michigan or University of Minnesota may become available as well, if that counts.
Apologize if this is a stupid question but isn't most tinnitus somatic?Jack if you looked at the criteria those with a hearing loss over a specific amount were excluded; as I think I recall somatic was excluded. There was no placebo, only different arms.
The fact is tinnitus has no focal point, it appears in different areas of the brain all contributing to it. Nobody can say this treatment will work for you even if you meet the criteria. That's the reality of it. The people who said it didn't work for them should not be ignored. We need to be realistic.
I think those others all sound like more fun, lol.And if this turns out to be an accepted treatment then I would much prefer this than getting needles in ear, taking tablets that alters brain chemistry or regenerating cells just to stop the ringing.
Not disputing what you've been told, but we need to be a bit careful when we're stating things as FACT.I got an email back from Sven Vanneste, a Belgian professor who is a scientific advisor for Neuromod and he said that's the expected release date for Belgium.
Nothing official though.
You can check my earlier posts.
Trust me, if they would have ringing tomorrow, the device would be out yesterday.Maybe one of us can ring them tomorrow
Ah that sucks! First it was January, then Q1, and now summer, I don't think it's healthy to keep checking this forum day by day. I am going to stop.The device will be called Lenire. It's currently in the trademark phase, opposition period ends in May 2019. I can say with certainty that they are not releasing it before June. We have more months to wait...
View attachment 26865
If they have postponed the release to make the device more effective I wholeheartedly agree and think it's a good idea as hope even if it's false hope is better than failure and suicide as a by product of said failure.Weirdly, I'm not that unhappy because of the postponed release.
I have been actively optimistic ever since January 2018, when Dr. Shore released her study which has shown that neuromodulation works for tinnitus.
However if that thing actually gets here and doesn't work... That would shake me deeply.
I'd rather prolong the hopeful anticipation than face shattered hopes...
Good stuff and thanks for bringing clarity. I have been researching this a lot today and learned way more than I wanted about trademark law. Haha.Law student here. You can absolutely sell your IP without a trademark. Trademarks apply to the mark's distinctiveness (ie. for branding) and not to a competitor's ability to copy the product. As long as they have a patent, their IP is protected.
If they don't have a trademark, they can still use the "Lenire" name and logo, but that wouldn't be protected.
On the one hand, it's unlikely that another medical device would be released using that name and logo, but Neuromod might prefer to get its ducks in a row before it releases a novel product.
Here is their patent: https://register.epo.org/application?number=EP16798699
Easier said than done. It's addictive surrounding yourself with reflective misery.I don't think it's healthy to keep checking this forum day by day. I am going to stop.
I have learned the hard way to limit my time on the internet support to one hour a day.I don't think it's healthy to keep checking this forum day by day. I am going to stop.
Yes. In the first year I spent all my time on a support board making friends becoming close and helping each other. It was a way for me to connect with people because the outside world was not an option for me. I guess it helped me survive to a point but it also created a different life experience that to this day...is one that has affected my life.Easier said than done. It's addictive surrounding yourself with reflective misery.
It's not going to work, for a lot of people. Whether you go by the percentages from the smaller Shore trial or the somewhat more optimistic numbers from Neuromod, neither of these devices is claiming to treat anything close to 100% of people. Some people respond. Others don't.Weirdly, I'm not that unhappy because of the postponed release.
I have been actively optimistic ever since January 2018, when Dr. Shore released her study which has shown that neuromodulation works for tinnitus.
However if that thing actually gets here and doesn't work... That would shake me deeply.
I'd rather prolong the hopeful anticipation than face shattered hopes...
My faith in these Irish clowns dwindles by the day. I have a sneaking suspicion that Shore's device when it finally arrives is going to be much more of the real deal and may deliver most tinnitus a knock out punch. Unfortunately it's going to be another 2 or probably 3 years. Lovely for all those people who get this in the future. Not so helpful for us poor bastards.Things would be different I suspect, if Susan Shore's and the University of Minnesota's devices were about to hit the market also.
Agreed. It sounds like a flaky admission of being fairly useless. Horribly like Levo.I wonder if the name change to Lenire is because MuteButton is too much of an over promise. Or else there's already trademarked range of buttons made by mute artisans?
Lenire means 'soothe' in Italian according to Google - seems appropriate.
If "MuteButton" doesn't 'Mute,' can they be 'done' under the Trades Descriptions Act??I wonder if the name change to Lenire is because MuteButton is too much of an over promise. Or else there's already trademarked range of buttons made by mute artisans?
Lenire means 'soothe' in Italian according to Googs - seems appropriate.
It almost seems like they assume that however they treat us, we will be buying their toy anyway.My faith in these Irish clowns dwindles by the day.
You bring up a good point, I think. However, I would argue that they do not need to convince competitors but health care systems and insurance companies. This might require larger trials.If they were a rip-off, or a scam, or did not have faith in their device, would they have done a trial with 500 test subjects? They could've stopped at 300 and rush to market. Just, do a bit more than the competitor. But this is a substantive trial.